Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach

Blood (2023) 142 (Supplement 1): 1636.

https://doi.org/10.1182/blood-2023-186950

Published: 2023

Journal Articles

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 2993.

https://doi.org/10.1182/blood-2023-186530

Published: 2023

Journal Articles

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Blood (2022) 140 (11): 1278–1290.

https://doi.org/10.1182/blood.2021015019

Published: 2022

Includes: Supplemental data

Journal Articles

VAV1 mutations contribute to development of T-cell neoplasms in mice

Kota Fukumoto, Mamiko Sakata-Yanagimoto, Manabu Fujisawa, Tatsuhiro Sakamoto, Hiroaki Miyoshi, Yasuhito Suehara, Tran B. Nguyen, Sakurako Suma, Shintaro Yanagimoto, Yuichi Shiraishi, Kenichi Chiba, Alyssa Bouska, Keisuke Kataoka, Seishi Ogawa, Javeed Iqbal, Koichi Ohshima, Shigeru Chiba

Blood (2020) 136 (26): 3018–3032.

https://doi.org/10.1182/blood.2020006513

Published: 2020

Includes: Supplemental data

Journal Articles

Single-Cell Transcriptomics of Human TET2 Knockout CD4 T-Cells and Their Clonal Evolution

Yuping Li, PhD, Xiaoqian Liu, MD PhD, Xuxiang Liu, PhD, Xiwei Wu, PhD, Alyssa Bouska, PhD, Waseem G. Lone, PhD, Chan-Wang J. Lio, PhD, Tyler Herek, BS,MS, Logan Lee, BS, Gehong Dong, MD PhD, Jinhui Wang, PhD, Chih-Hong Lou, PhD, Wei Qi, MD, Kunal Shetty, BS, Timothy W. McKeithan, MD PhD, Javeed Iqbal, PhD, Wing (John) C. Chan, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-143113

Published: 2020

Journal Articles

DNMT3A Mutations Identify a Prognostic Subgroup in Peripheral T-Cell Lymphoma

Tyler A. Herek, BS,MS, Alyssa Bouska, PhD, Waseem G. Lone, PhD, Tayla B. Heavican, PhD, Catalina Amador, MD, Sunandini Sharma, BS, d'Amore Francesco, MDPhD, Wing C. Chan, MD, Javeed Iqbal, PhD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-143335

Published: 2020

Journal Articles

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Blood (2019) 134 (24): 2159–2170.

https://doi.org/10.1182/blood.2019000779

Published: 2019

Includes: Supplemental data

Journal Articles

Genome-Wide microRNA Expression Profiling in Molecular Subgroups of Peripheral T-Cell Lymphoma Identified Role of Mir-126 in T-Cell Lymphomagenesis

Waseem Lone, PhD, Alyssa Bouska, PhD, Tyler Herek, BS,MS, Catalina Amador, MD, Mallick Saumyaranajn, MD, Yu Jiayu, Tayla Heavican, Stefano A. Pileri, MD PhD, Timothy McKeithan, MD PhD, Wing C. Chan, MD, Javeed Iqbal, PhD

Blood (2019) 134 (Supplement_1): 2767.

https://doi.org/10.1182/blood-2019-129327

Published: 2019

Journal Articles

Genomic Characterization of Diffuse Large B-Cell Lymphoma Transformation from Nodular Lymphocyte Predominant Hodgkin Lymphoma

Joo Y. Song, MD, Caoimhe Egan, Alyssa Bouska, PhD, Weiwei Zhang, PhD, Qiang Gong, Girish Venkataraman, MD MBBS, Alex F. Herrera, MD, Lu Chen, PhD, Rebecca Ottesen, Joyce Niland, PhD, Victoria Bedell, Maria Valle-Catuna, Joyce Murata-Collins, PhD, Dennis D. Weisenburger, MD, Javeed Iqbal, PhD, Elaine S. Jaffe, MD, Wing C. Chan, MD

Blood (2019) 134 (Supplement_1): 1486.

https://doi.org/10.1182/blood-2019-125095

Published: 2019

Journal Articles

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Blood (2019) 133 (15): 1664–1676.

https://doi.org/10.1182/blood-2018-09-872549

Published: 2019

Includes: Supplemental data

Journal Articles

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore, MD, Sirpa Leppä, MD, Maria Gomes da Silva, MD PhD, Thomas Relander, Grete Fossum Lauritzsen, Peter De Nully Brown, Antonio Pezzutto, Jeanette K. Doorduijn, MD PhD, Eckhart Weidmann, Michel van Gelder, Achiel Van Hoof, Ilse Christiansen, Unn Merete Fagerli, MD PhD, Hans Hagberg, MD, P.J. Lugtenburg, Jan Walewski, Ka Lung Wu, Hilde Maria Demuynck, Rob Fijnheer, Jacob H. Christensen, Milada Jankovská, MD, Pär L. Josefsson, Hanneke Kluin-Nelemans, Jose Mario Mariz, MD, Mats A. Merup, Thomas Noesslinger, Eric Van Den Neste, Josée M Zijlstra, MD, Georg Hopfinger, MD, VIT Prochazka, MD, Esa Jantunen, MD PhD, Ludmila Boudova, Jose Cabecadas, Andreas Chott, Jan M.A. Delabie, MD PhD, Laurence de Leval, MD, Arjan Diepstra, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Peter Noergaard, Andreas Rosenwald, Grzegorz Rymkiewicz, Christer Sundström, Lorenz Truemper, MD, Gerald Wulf, MD, Lauren Chong, MSc, Alyssa Bouska, PhD, Lynette Smith, Christian Gisselbrecht, Marita Ziepert, PhD, Markus Loeffler, MD, Knut Liestol, Christian Steidl, MD, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Bettina Altmann, PhD, Javeed Iqbal, §, Wing C Chan, MD, Helle Toldbod, MS,PhD

Blood (2018) 132 (Supplement 1): 998.

https://doi.org/10.1182/blood-2018-99-110429

Published: 2018

Journal Articles

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

Blood (2017) 130 (16): 1819–1831.

https://doi.org/10.1182/blood-2017-02-767335

Published: 2017

Includes: Supplemental data

Journal Articles

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Blood (2016) 128 (22): 4095.

https://doi.org/10.1182/blood.V128.22.4095.4095

Published: 2016

Journal Articles

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Blood (2016) 128 (22): 4096.

https://doi.org/10.1182/blood.V128.22.4096.4096

Published: 2016

Journal Articles

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 2686.

https://doi.org/10.1182/blood.V128.22.2686.2686

Published: 2016

Journal Articles

Long Non Coding RNA Signatures with Diagnostic and Prognostic Significance in Aggressive B-Cell Lymphoma

Jiayu Yu, Alyssa Bouska, PhD, Waseem Lone, PhD, Chengfeng Bi, MD PhD, Tayla Heavican, Kai Fu, MD PhD, Timothy C. Greiner, MD, Wing Chung Chan, MD, Javeed Iqbal, PhD

Blood (2016) 128 (22): 1759.

https://doi.org/10.1182/blood.V128.22.1759.1759

Published: 2016

Journal Articles

Molecular Features of Germinal Cell Derived B-Cell Lymphomas Using miRNA Signatures

Aisha Al-Khinji, MD, Ellen Leich, Tathiana Andrade, Alyssa Bouska, PhD, Waseem Lone, PhD, Stefan Constinean, MD, Kai Fu, MD PhD, Andreas Rosenwald, MD, Wing Chung Chan, MD, Javeed Iqbal, PhD

Blood (2016) 128 (22): 5288.

https://doi.org/10.1182/blood.V128.22.5288.5288

Published: 2016

Journal Articles

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

Blood (2015) 126 (15): 1741–1752.

https://doi.org/10.1182/blood-2015-05-644591

Published: 2015

Includes: Supplemental data

Journal Articles

CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression

Blood (2014) 124 (21): 1681.

https://doi.org/10.1182/blood.V124.21.1681.1681

Published: 2014

Journal Articles

IDH2 R172 Mutations Define a Unique Subgroup of Patients in Angioimmunoblastic T-Cell Lymphoma

Blood (2014) 124 (21): 3580.

https://doi.org/10.1182/blood.V124.21.3580.3580

Published: 2014

NARROW

Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

VAV1 mutations contribute to development of T-cell neoplasms in mice

Single-Cell Transcriptomics of Human TET2 Knockout CD4 T-Cells and Their Clonal Evolution

DNMT3A Mutations Identify a Prognostic Subgroup in Peripheral T-Cell Lymphoma

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

Genome-Wide microRNA Expression Profiling in Molecular Subgroups of Peripheral T-Cell Lymphoma Identified Role of Mir-126 in T-Cell Lymphomagenesis

Genomic Characterization of Diffuse Large B-Cell Lymphoma Transformation from Nodular Lymphocyte Predominant Hodgkin Lymphoma

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

Long Non Coding RNA Signatures with Diagnostic and Prognostic Significance in Aggressive B-Cell Lymphoma

Molecular Features of Germinal Cell Derived B-Cell Lymphomas Using miRNA Signatures

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression

IDH2 R172 Mutations Define a Unique Subgroup of Patients in Angioimmunoblastic T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only